Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.

Rahman MR, Islam T, Zaman T, Shahjaman M, Karim MR, Huq F, Quinn JMW, Holsinger RMD, Gov E, Moni MA.

Genomics. 2019 Aug 1. pii: S0888-7543(19)30184-3. doi: 10.1016/j.ygeno.2019.07.018. [Epub ahead of print]

PMID:
31377428
2.

SGEF forms a complex with Scribble and Dlg1 and regulates epithelial junctions and contractility.

Awadia S, Huq F, Arnold TR, Goicoechea SM, Sun YJ, Hou T, Kreider-Letterman G, Massimi P, Banks L, Fuentes EJ, Miller AL, Garcia-Mata R.

J Cell Biol. 2019 Aug 5;218(8):2699-2725. doi: 10.1083/jcb.201811114. Epub 2019 Jun 27.

PMID:
31248911
3.

Discovering Biomarkers and Pathways Shared by Alzheimer's Disease and Ischemic Stroke to Identify Novel Therapeutic Targets.

Rahman MR, Islam T, Shahjaman M, Zaman T, Faruquee HM, Jamal MAHM, Huq F, Quinn JMW, Moni MA.

Medicina (Kaunas). 2019 May 22;55(5). pii: E191. doi: 10.3390/medicina55050191.

4.

Genetic effects of welding fumes on the development of respiratory system diseases.

Rana HK, Akhtar MR, Islam MB, Ahmed MB, Liò P, Quinn JMW, Huq F, Moni MA.

Comput Biol Med. 2019 May;108:142-149. doi: 10.1016/j.compbiomed.2019.04.004. Epub 2019 Apr 8.

PMID:
31005006
5.

Anillin regulates epithelial cell mechanics by structuring the medial-apical actomyosin network.

Arnold TR, Shawky JH, Stephenson RE, Dinshaw KM, Higashi T, Huq F, Davidson LA, Miller AL.

Elife. 2019 Jan 31;8. pii: e39065. doi: 10.7554/eLife.39065.

6.

Genetic effects of welding fumes on the progression of neurodegenerative diseases.

Rana HK, Akhtar MR, Ahmed MB, Liò P, Quinn JMW, Huq F, Moni MA.

Neurotoxicology. 2019 Mar;71:93-101. doi: 10.1016/j.neuro.2018.12.002. Epub 2018 Dec 17.

PMID:
30571986
7.

Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action.

Alam MN, Almoyad M, Huq F.

Biomed Res Int. 2018 Jan 15;2018:4154185. doi: 10.1155/2018/4154185. eCollection 2018. Review.

8.

Long-term Hearing Preservation After Resection of Vestibular Schwannoma: A Systematic Review and Meta-analysis.

Ahsan SF, Huq F, Seidman M, Taylor A.

Otol Neurotol. 2017 Dec;38(10):1505-1511. doi: 10.1097/MAO.0000000000001560. Review.

PMID:
29140965
9.

Changes in the in vitro activity of platinum drugs when administered in two aliquots.

Al-Eisawi Z, Beale P, Chan C, Yu JQ, Proschogo N, Molloy M, Huq F.

BMC Cancer. 2016 Aug 26;16:688. doi: 10.1186/s12885-016-2731-1.

11.

Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models.

Arzuman L, Beale P, Proschogo N, Yu JQ, Huq F.

Anticancer Res. 2015 Nov;35(11):6027-39.

PMID:
26504026
12.

Radionecrosis 30 years after breast cancer.

Huq F, Pai MD, Potdar N.

Indian J Surg. 2015 Apr;77(Suppl 1):81-3. doi: 10.1007/s12262-014-1153-z. Epub 2014 Aug 13.

14.

Biomechanical evaluation of human and porcine auricular cartilage.

Zopf DA, Flanagan CL, Nasser HB, Mitsak AG, Huq FS, Rajendran V, Green GE, Hollister SJ.

Laryngoscope. 2015 Aug;125(8):E262-8. doi: 10.1002/lary.25040. Epub 2015 Apr 17.

15.

Variations in the cochlear implant experience in children with enlarged vestibular aqueduct.

Pritchett C, Zwolan T, Huq F, Phillips A, Parmar H, Ibrahim M, Thorne M, Telian S.

Laryngoscope. 2015 Sep;125(9):2169-74. doi: 10.1002/lary.25187. Epub 2015 Feb 3.

16.

Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.

Arzuman L, Beale P, Yu JQ, Proschogo N, Huq F.

Anticancer Res. 2014 Dec;34(12):7077-90.

PMID:
25503135
17.

Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.

Chowdary P, Adamidou D, Riddell A, Aghighi S, Griffioen A, Priest P, Moghadam L, Kelaher N, Huq FY, Kadir RA, Tuddenham EG, Gatt A.

Br J Haematol. 2015 Mar;168(5):719-27. doi: 10.1111/bjh.13193. Epub 2014 Oct 29.

PMID:
25351814
20.

CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia.

Green GE, Huq FS, Emery SB, Mukherji SK, Martin DM.

Otol Neurotol. 2014 Sep;35(8):1466-70. doi: 10.1097/MAO.0000000000000260.

21.

Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.

Hamad SA, Beale P, Yu JQ, Huq F.

J Biomed Sci. 2014 May 12;21:41. doi: 10.1186/1423-0127-21-41.

23.

Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer.

Huq F, Yu JQ, Beale P, Chan C, Arzuman L, Nessa MU, Mazumder ME.

Anticancer Res. 2014 Jan;34(1):541-5.

PMID:
24403514
24.

Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models.

Al-Eisawi Z, Beale P, Chan C, Yu JQ, Huq F.

J Ovarian Res. 2013 Nov 9;6(1):78. doi: 10.1186/1757-2215-6-78.

25.

Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines.

Yunos NM, Mutalip SS, Jauri MH, Yu JQ, Huq F.

Anticancer Res. 2013 Oct;33(10):4365-71.

PMID:
24123004
26.

TEMPL3: a simple mnemonic for the diagnosis of temporal arteritis.

Cumberworth A, Norris JM, Huq F, Smith M.

Br J Hosp Med (Lond). 2012 Dec;73(12):714. No abstract available.

PMID:
23577360
27.
28.

Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.

Mazumder ME, Beale P, Chan C, Yu JQ, Huq F.

Anticancer Res. 2012 Nov;32(11):4851-60.

PMID:
23155251
29.
30.

Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.

Deqnah N, Qing Yu J, Beale P, Fisher K, Huq F.

Med Chem. 2013 Jun 1;9(4):539-44.

PMID:
23061563
31.

Synthesis, characterization and antitumor activity of new ferrocene incorporated N,N'-disubstituted thioureas.

Lal B, Badshah A, Altaf AA, Tahir MN, Ullah S, Huq F.

Dalton Trans. 2012 Dec 28;41(48):14643-50. doi: 10.1039/c2dt31570j.

PMID:
23051687
32.

Synthesis and cytotoxicity of three trans-palladium complexes containing planaramine ligands in human ovarian tumor models.

Mazumder ME, Beale P, Chan C, Yu JQ, Huq F.

ChemMedChem. 2012 Oct;7(10):1840-6. doi: 10.1002/cmdc.201200310. Epub 2012 Aug 16.

PMID:
22899663
33.

Hypothalamic hamartoma with precocious puberty: a case report.

Amin MS, Kader MA, Huq FI, Khan NA.

Mymensingh Med J. 2012 Jul;21(3):553-6.

PMID:
22828561
34.
35.

Attitudes of Cairo University medical students toward smoking: the need for tobacco control programs in medical education.

Khan AA, Dey S, Taha AH, Huq FS, Moussawi AH, Omar OS, Soliman AS.

J Egypt Public Health Assoc. 2012 Apr;87(1-2):1-7. doi: 10.1097/01.EPX.0000411467.14763.0b.

36.
37.

Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.

Deqnah N, Yu JQ, Beale P, Fisher K, Huq F.

Anticancer Res. 2012 Jan;32(1):135-40.

PMID:
22213298
38.

Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.

Nessa MU, Beale P, Chan C, Yu JQ, Huq F.

Anticancer Res. 2012 Jan;32(1):53-9.

PMID:
22213288
39.

Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.

Yunos NM, Beale P, Yu JQ, Huq F.

Anticancer Res. 2011 Dec;31(12):4283-9.

PMID:
22199293
40.

The outcome of endometrial ablation in women with inherited bleeding disorders.

Huq FY, Al-Haderi M, Kadir RA.

Haemophilia. 2012 May;18(3):413-20. doi: 10.1111/j.1365-2516.2011.02712.x. Epub 2011 Dec 21.

PMID:
22188607
41.

Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.

Nessa MU, Beale P, Chan C, Yu JQ, Huq F.

Anticancer Res. 2011 Nov;31(11):3789-97.

PMID:
22110201
42.

Changes in the levels of factor VIII and von Willebrand factor in the puerperium.

Huq FY, Kulkarni A, Agbim EC, Riddell A, Tuddenham E, Kadir RA.

Haemophilia. 2012 Mar;18(2):241-5. doi: 10.1111/j.1365-2516.2011.02625.x. Epub 2011 Sep 28.

PMID:
21951573
43.

Postoperative outcomes following closed head injury and craniotomy for evacuation of hematoma in patients older than 80 years.

Lau D, El-Sayed AM, Ziewacz JE, Jayachandran P, Huq FS, Zamora-Berridi GJ, Davis MC, Sullivan SE.

J Neurosurg. 2012 Jan;116(1):234-45. doi: 10.3171/2011.7.JNS11396. Epub 2011 Aug 26.

PMID:
21888477
44.

Modulation of cisplatin cytotoxicity due to its combination with bortezomib and the nature of its administration.

Al-Eisawi Z, Beale P, Chan C, Yu JQ, Huq F.

Anticancer Res. 2011 Sep;31(9):2757-62.

PMID:
21868517
45.

Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study.

Al-Shuneigat JM, Mahgoub SS, Huq F.

J Biomed Sci. 2011 Jul 25;18(1):50. doi: 10.1186/1423-0127-18-50.

46.

Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation.

Huq FY, Tvarkova K, Arafa A, Kadir RA.

Contraception. 2011 Aug;84(2):128-32. doi: 10.1016/j.contraception.2010.12.011. Epub 2011 Feb 11.

PMID:
21757053
47.

trans-Bis(3-hy-droxy-pyridine-κN)diiodidoplatinum(II) dimethyl sulfoxide disolvate.

Huq F, Danish M, Starosta W, Leciejewicz J.

Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 1;67(Pt 6):m721. doi: 10.1107/S1600536811015893. Epub 2011 May 7.

48.

Management of pregnancy, labour and delivery in women with inherited bleeding disorders.

Huq FY, Kadir RA.

Haemophilia. 2011 Jul;17 Suppl 1:20-30. doi: 10.1111/j.1365-2516.2011.02561.x. Review.

PMID:
21692925
49.
50.

Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.

Chi C, Huq FY, Kadir RA.

Contraception. 2011 Mar;83(3):242-7. doi: 10.1016/j.contraception.2010.07.010. Epub 2010 Aug 30.

PMID:
21310286

Supplemental Content

Support Center